Leucocytosis during all-trans retinoic acid and arsenic trioxide treatment in acute promyelocytic leukaemia

被引：0

作者：

Yanada, Masamitsu ^{[1
]}

机构：

[1] Nagoya City Univ, East Med Ctr, 1-2-23 Wakamizu,Chikusa Ku, Nagoya 4648547, Japan

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 2024年 / 205卷 / 05期

基金：

日本学术振兴会;

关键词：

acute promyelocytic leukaemia; all-trans retinoic acid; arsenic trioxide; differentiation syndrome; leucocytosis; EARLY DEATH; CENTERS; APL;

D O I：

10.1111/bjh.19763

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

In patients with acute promyelocytic leukaemia (APL), differentiation syndrome (DS) is a life-threatening complication caused by the differentiating effect of all-trans retinoic acid (ATRA) and/or arsenic trioxide (ATO). Leucocytosis is frequently observed during induction therapy for APL and is intimately associated with the development of DS and its severity. The management of DS is particularly important due to the high likelihood of excellent outcomes for APL patients who successfully complete induction therapy. Commentary on: Cicconi et al. Leukocytosis during induction therapy with all-trans-retinoic acid and arsenic trioxide in acute promyelocytic leukemia predicts for differentiation syndrome and treatment-related complications. Br J Haematol 2024 (Online ahead of print). doi: .

引用

页码：1672 / 1673

页数：2

共 50 条

[31] Intravascular haemolysis complicating treatment of acute promyelocytic leukaemia with all-trans retinoic acid (ATRA)
Hogan, CJ
Wiley, JS
Billington, T
AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1997, 27 (04): : 450 - 451
[32] Sublingual Capsular All-trans Retinoic Acid for Induction Treatment of Acute Promyelocytic Leukaemia in a Child
Tong, G. P. Y.
Chiu, J. K. H.
Luk, C. W.
Ha, S. Y.
HONG KONG JOURNAL OF PAEDIATRICS, 2023, 28 (01) : 41 - 45
[33] Chemokine induction by all-trans retinoic acid and arsenic trioxide in acute promyelocytic leukemia: triggering the differentiation syndrome
Luesink, Maaike
Pennings, Jeroen L. A.
Wissink, Willemijn M.
Linssen, Peter C. M.
Muus, Petra
Pfundt, Rolph
de Witte, Theo J. M.
van der Reijden, Bert A.
Jansen, Joop H.
BLOOD, 2009, 114 (27) : 5512 - 5521
[34] Serum thrombopoietin and erythropoietin levels in patients with acute promyelocytic leukaemia during all-trans retinoic acid treatment
Kinjo, K
Kizaki, M
Takayama, N
Michikawa, N
Oda, A
Okamoto, SI
Tahara, T
Kato, T
Miyazaki, H
Ikeda, Y
BRITISH JOURNAL OF HAEMATOLOGY, 1999, 105 (02) : 382 - 387
[35] A case of all-trans retinoic acid-induced myositis in the treatment of acute promyelocytic leukaemia
Chan, KH
Yuen, SLS
Joshua, D
CLINICAL AND LABORATORY HAEMATOLOGY, 2005, 27 (06): : 399 - 401
[36] Cost-Effectiveness Of Arsenic Trioxide plus All-Trans Retinoic Acid Compared With All-Trans Retinoic Acid plus Idarubicin In The Treatment Of Newly Diagnosed Acute Promyelocytic Leukemia In Canada
Lachaine, Jean
Mathurin, Karine
Barakat, Stephane
BLOOD, 2013, 122 (21)
[37] Use of all-trans retinoic acid plus arsenic trioxide as alternative to chemotherapy in untreated acute promyelocytic leukemia
Estey, E.
ANNALS OF HEMATOLOGY, 2006, 85 : 67 - 68
[38] Use of all-trans retinoic acid plus arsenic trioxide as an alternative to chemotherapy in untreated acute promyelocytic leukemia
Estey, E
Garcia-Manero, G
Ferrajoli, A
Faderl, S
Verstovsek, S
Jones, D
Kantarjian, H
BLOOD, 2006, 107 (09) : 3469 - 3473
[39] Effect of all-trans retinoic acid and arsenic trioxide on tissue factor expression in acute promyelocytic leukemia cells
郭为民
王鸿利
赵维莅
诸江
璩斌
王学峰
Chinese Medical Journal, 2001, (01)
[40] Successful treatment of acute promyelocytic leukemia with arsenic trioxide and all-trans retinoic acid in a double lung and kidney transplanted patient
Pierre Peterlin
Alice Garnier
Adrien Tissot
Claire Garandeau
Delphine Houreau-Langlard
Maryvonne Hourmant
Sophie Vantyghem
Antoine Bonnet
Thierry Guillaume
Marie C Béné
Steven Le Gouill
Philippe Moreau
Patrice Chevallier
Annals of Hematology, 2016, 95 : 1737 - 1738

← 1 2 3 4 5 →